ANG-PD · American National Group Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Annuity investment spread | 1.7% | Twelve Months Ended March 31, 2026 | -5.6% |
|
|
|||
| Distributable operating earnings non-GAAP | $360M | Q4 2025 | — |
| Total adjusted common stockholders' equity non-GAAP | $9.53B | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ANG-PD
this stock
American National Group Inc.
|
$234,650 | -6.2% | -0.4% | — | — |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | +0.3% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.89B | +22.5% | — | — | 0.8% |
|
MET
Metlife Inc
|
$62.06B | +23.7% | +8.6% | 18.7 | 1.8% |
|
AFL
Aflac Inc
|
$60.89B | +10.1% | -9.3% | 13.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ANG-PD | -0.8% | -1.2% | -7.0% | -1.3% | -6.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.2% | -5.7% | -20.8% | -5.2% | -20.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.